财务业绩 - 总收入为1.267亿美元，同比增长17%[4] - 净利润为4,140万美元，同比增长46%，非GAAP净利润为5,590万美元，同比增长38%[5] - 调整后EBITDA为6,590万美元，同比增长42%，调整后EBITDA利润率为52%[6] - 每股摊薄净收益为0.21美元，非GAAP每股摊薄净收益为0.28美元[7] - 经营活动现金流为4,120万美元，自由现金流为3,950万美元[8] - 预计第二季度收入在1.265亿美元至1.275亿美元之间，调整后EBITDA在6,250万美元至6,350万美元之间[9] - 预计全年收入在5.14亿美元至5.23亿美元之间，调整后EBITDA在2.485亿美元至2.575亿美元之间[9] 非GAAP财务指标 - 公司使用非GAAP财务指标来补充GAAP财务报表，包括非GAAP毛利、非GAAP营业收入、非GAAP净收入等[25] - 公司计算调整后EBITDA时剔除了股票激励费用、收购无形资产摊销、或有对价公允价值变动等项目[23] - 公司计算自由现金流时扣除了资本支出和内部使用软件开发成本[24] - 公司的非GAAP毛利率为91.6%，高于GAAP毛利率89.3%[33] - 公司的非GAAP营业收入为6440万美元，高于GAAP营业收入4605万美元[38] - 公司的非GAAP净收入为5587.6万美元，非GAAP净收入率为44.1%[40] - 公司的非GAAP每股收益为基本0.30美元、稀释0.28美元[42] - 公司计算非GAAP指标时采用的年度有效税率为21.0%[43] 业务发展 - 公司网络成员包括超过80%的美国医生[11] - 公司致力于帮助医生提高工作效率以更好地为患者服务[11] - 公司的净收入续存率是其收入增长的关键指标[26]

Doximity (DOCS) closed the most recent trading day at $28.66, moving +1.49% from the previous trading session. The stock's change was more than the S&P 500's daily loss of 0.5%. Meanwhile, the Dow gained 0.5%, and the Nasdaq, a tech-heavy index, lost 1.28%.Shares of the medical social networking site witnessed a gain of 2.8% over the previous month, beating the performance of the Medical sector with its gain of 0.74% and the S&P 500's gain of 0.1%.The upcoming earnings release of Doximity will be of great i ...

The three-year-long historic public health crisis significantly altered the structure and trend of the Medical Services sector. The growing demand for remote treatment led to a tremendous upsurge in digital healthcare options. Demand for digital healthcare treatment continues to grow in the form of telemedicine-focused online medical and AI-powered technology services backed by the adoption of data and analytics.According to a recent Mordor Intelligence report, the global healthcare analytics market is expe ...

The most recent trading session ended with Doximity (DOCS) standing at $27.97, reflecting a +0.5% shift from the previouse trading day's closing. This move outpaced the S&P 500's daily loss of 0.41%. Meanwhile, the Dow experienced a drop of 0.12%, and the technology-dominated Nasdaq saw a decrease of 0.71%. The medical social networking site's shares have seen an increase of 0.29% over the last month, not keeping up with the Medical sector's gain of 1.74% and the S&P 500's gain of 3.53%. Market participants ...

NEW YORK, June 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (NYSE: DOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022 to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company. Doximity ope ...

RADNOR, Pa., June 14, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE: DOCS) (“Doximity” or the “Company”) on behalf of investors who purchased or acquired Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the “Class Period”). This action, captioned Kissler v. Doximity, Inc., et al., Case No. 3:24-cv-02281-JST was filed in the United States Di ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. ("Doximity" or the "Company") (NYSE:DOCS) and reminds investors of the June 17, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Doximity ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) and reminds investors of the June 17, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Doximit ...

RADNOR, Pa., June 10, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE: DOCS) ("Doximity" or the "Company") on behalf of investors who purchased or acquired Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the "Class Period"). This action, captioned Kissler v. Doximity, Inc., et al., Case No. 3:24-cv-02281-JST was filed in the United States Distri ...

NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Doximity, Inc. (NYSE: DOCS)? Did you purchase your shares between February 9, 2022 and April 1, 2024, inclusive? Did you lose money in your investment in Doximity, Inc.? Do you want to discuss your rights? Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of Doximity, Inc. (“Doximity” or the “Company”) (NY ...